By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


bluebird bio 

840 Memorial Drive

Cambridge  Massachusetts  02139  U.S.A.
Phone: 617-491-5601 Fax: 617-576-2421



Gene Therapy

Company News
bluebird bio (BLUE) Announces First Patient With Sickle Cell Disease Transplanted With LentiGlobin Gene Therapy 10/14/2014 8:35:58 AM
bluebird bio (BLUE) To Present At Morgan Stanley (MST) Global Health Care Conference 9/3/2014 1:27:09 PM
bluebird bio (BLUE) Reports Fiscal Second Quarter 2014 Financial Results 8/13/2014 7:54:00 AM
bluebird bio (BLUE) To Present At Two Upcoming Health Care Conferences 8/6/2014 9:16:22 AM
bluebird bio (BLUE) Appoints Mark Vachon To Its Board Of Directors 7/17/2014 11:19:05 AM
bluebird bio (BLUE) Announces Proposed Public Offering Of Common Stock 7/8/2014 11:17:58 AM
Massachusett's bluebird bio (BLUE) Snaps Up Pregenen For Up To $139.9 Million 7/1/2014 6:53:33 AM
Cambridge-Based bluebird bio (BLUE)'s Gene Therapy Quickly Halts Blood Disease In Small Study; Stock Up 32.08% At Market Close (June 16, 2014) 6/16/2014 6:41:51 AM
bluebird bio To Host A Conference Call To Discuss Initial Results From The HGB-205 Study In Beta-Thalassemia Major Subjects 6/10/2014 6:45:43 AM
bluebird bio Reports Fiscal First Quarter 2014 Financial Results 5/14/2014 7:41:10 AM